Ruth Puig-Peiro
Ruth Puig-Peiro
Center for Research in Economics and Health (CRES) - Pompeu Fabra University
Correu electrònic verificat a upf.edu - Pàgina d'inici
Títol
Citada per
Citada per
Any
Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study
F Valldeoriola, J Puig-Junoy, R Puig-Peiró, ...
Journal of medical economics 16 (2), 191-201, 2013
432013
Drug evaluation and decision making in Catalonia: development and validation of a methodological framework based on multi-criteria decision analysis (MCDA) for orphan drugs
A Gilabert-Perramon, J Torrent-Farnell, A Catalan, A Prat, M Fontanet, ...
International journal of technology assessment in health care 33 (1), 111, 2017
262017
Projecting expenditure on medicines in the UK NHS
P O’Neill, J Mestre-Ferrandiz, R Puig-Peiro, J Sussex
PharmacoEconomics 31 (10), 933-957, 2013
92013
The use of pay-for-performance for drugs: Can it improve incentives for innovation?
A Towse, L Garrison, R Puig-Peiró
Incentives for Research, Development, and Innovation in Pharmaceuticals, 69-80, 2011
92011
Understanding variations in relative effectiveness: A health production approach
A Towse, B Jonsson, C McGrath, A Mason, R Puig-Peiro, ...
International journal of technology assessment in health care 31 (6), 363-370, 2015
82015
Impacto económico de las exacerbaciones agudas en EPOC desde la perspectiva del SNS español
M Pérez, R Puig-Peiró, S Aceituno, L Lizán
Rev Patol Respir 19 (3), 89-95, 2016
62016
Cost–effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain
D Nieves, R Puig-Peiró, C Ferrándiz, MJ Plazas, M Brosa
Expert review of pharmacoeconomics & outcomes research 15 (3), 539-543, 2015
62015
Researching the relative efficacy and relative effectiveness of medicines across Europe
J Mestre-Ferrandiz, R Puig-Peiró, A Towse
Consulting Reports, 2010
62010
La financiación del sistema para la autonomía y atención a la dependencia: proyecciones de gasto 2007-2015
DC Marín, AT Prats, RP Peiró
Centre de Recerca en Economia i Salut, Universitat Pompeu Fabra Barcelona, 2008
52008
Coste directo de la Enfermedad Pulmonar Obstructiva Crónica asociado a variaciones en adherencia y persistencia
M Pérez, R Puig-Peiró, S Paz, L Lizán
Rev Patol Respir 18, 49-56, 2015
42015
RS1 Literature Review On Patient Access Schemes, Flexible Pricing Schemes And Risk Sharing Agreements For Medicines
R Puig-Peiró, J Mestre-Ferrandiz, J Sussex, A Towse
Value in Health 14 (7), A243, 2011
42011
HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for health care decision-making in catalonia (spain): pilot study focused in orphan drugs
A Gilabert-Perramon, J Torrent-Farnell, A Catalan, A Prat, M Fontanet, ...
Value in Health 19 (7), A353, 2016
32016
Relative effectiveness in breast cancer treatment: A health production approach
R Puig-Peiro, A Mason, J Mestre-Ferrandiz, A Towse, C McGrath, ...
International journal of technology assessment in health care 31 (6), 371-379, 2015
32015
Incentivos a la I+ D+ i de medicamentos
WA Garcia-Fontes
Springer Science & Business Media, 2012
32012
Revisión de la evidencia económica sobre el uso de la estimulación cerebralprofunda en la enfermedad de Parkinson avanzada
J Puig-Junoy, R Puig Peiró
Neurologia 24, 220-229, 2009
32009
Letter to the editor regarding the paper by A. Lozano-Blázquez et al. Differences in cancer drug assessment between Spain and the United Kingdom
A Prat, A Gilabert, R Puig-Peiro, A Feliu, M Riba, MA Mangues, ...
European Journal of Cancer 67, 55-56, 2016
12016
INSTRUMENTS FOR THE INCORPORATION OF ECONOMIC EVALUATION, BUDGETARY IMPACT AND SCHEMES OF PAYMENT BY RESULTS IN THE CATALAN HEALTH SERVICE (SPAIN)
M Brosa, J Puig-Junoy, M Gasol-Boncompte, L Segu-Tolsa, ...
VALUE IN HEALTH 18 (7), A855-A855, 2015
12015
International Comparisons of Medicines Prices: 2011 Indices
P O'Neill, R Puig-Peiro, J Mestre-Ferrandiz, J Sussex
Consulting Reports, 2012
12012
Time trends in NICE HTA decisions
P O'Neill, N Devlin, R Puig-Peiro
Consulting Reports, 2012
12012
1.142 COST ANALYSIS OF THE TREATMENTS FOR PATIENTS WITH COMPLICATED PARKINSON'S DISEASE: SCOPE STUDY
F Valldeoriola, J Puig-Junoy, R Puig-Peiró, P González
Parkinsonism & Related Disorders 18, S46, 2012
12012
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20